XML 93 R81.htm IDEA: XBRL DOCUMENT v3.23.3
Deferred Income and Revenue (Details) - EUR (€)
€ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
May 31, 2023
Dec. 31, 2021
Disclosure of information about amounts recognised in relation to regulatory deferral account balances [line items]          
Revenue € 15,374 € 12,188      
Other income 3,893 3,398      
Other income 3,893 3,398      
Increase (Decrease) of Research Tax Credit Receivable     € 6,017   € 5,282
Tax expense (income) 414 40      
Other Operating Income [Member]          
Disclosure of information about amounts recognised in relation to regulatory deferral account balances [line items]          
Other income 263 46      
Ipsen          
Disclosure of information about amounts recognised in relation to regulatory deferral account balances [line items]          
Upfront payment received         120,000
Deferred income         € 40,000
Deferred income current 11,100        
Deferred income non-current 4,800        
Deferred income other than contract liabilities 15,900        
Partial recognition of deferred revenue 8,200 8,200      
Ipsen | Transition Services Agreement          
Disclosure of information about amounts recognised in relation to regulatory deferral account balances [line items]          
Revenue 3,200 € 600      
Seal Rock [Member]          
Disclosure of information about amounts recognised in relation to regulatory deferral account balances [line items]          
Milestone payments € 98,000     € 100,000  
Genfit Corp          
Disclosure of information about amounts recognised in relation to regulatory deferral account balances [line items]          
Tax expense (income)     € 196